To include your compound in the COVID-19 Resource Center, submit it here.

Actimmune interferon gamma-1b: Completed Phase III enrollment

Horizon completed enrollment of 90 patients in the double-blind, placebo-controlled, U.S. Phase III STEADFAST trial evaluating

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE